Topiramate's effects on alcohol use similar to FDA-approved drugs

    loading  Checking for direct PDF access through Ovid

Abstract

A meta-analysis of seven randomized controlled trials, comprising 1,125 patients, has found that the antiepileptic drug topiramate is moderately effective compared with placebo in reducing alcohol consumption in individuals with alcohol use disorders. Effect sizes in the examined trials were comparable to those for naltrexone and acamprosate, the most frequently studied of the medications approved by the Food and Drug Administration (FDA) for alcohol dependence.

Related Topics

    loading  Loading Related Articles